Basic Information
Mesoblast is an Australian stem cell therapy product developer with a mesenchymal lineage adult stem cell (MLC) and mesenchymal precursor cell (MPC) adult stem cell technology platform. It has developed a series of allogeneic stem cell therapy products for clinical use (e.g., off-the-shelf stem cells MPC-150-IM), focusing on treatments for cardiovascular diseases, rheumatological and immunological diseases, metabolic diseases, and more.
Mesoblast Limited
Melbourne,Victoria,Australia
more than 500 people
January 01, 2004
info@mesoblast.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios